BioNTX Marks the Close of the First Quarter of the 21st Century with Growth, Workforce Momentum, and Innovation Leadership
IRVING, Texas, Dec. 31, 2025 (GLOBE NEWSWIRE) -- As 2025 ends, BioNTX…
GAC Receives Industry’s First Vehicle Data Security Management System Certificate
TIANJIN, China and GUANGZHOU, China, Dec. 31, 2025 /PRNewswire/ -- On December…
Best Weight Loss Pills for 2026? FDA Approves First Oral GLP-1 as Patients Evaluate Wegovy, Zepbound, and Telehealth Access Pathways
Newark, DE, Dec. 29, 2025 (GLOBE NEWSWIRE) -- The term "best" reflects…
OBOOK Holdings Inc. Announces Unaudited Financial Results for the First Half of 2025 Ended June 30, 2025; Core Infrastructure Transition Near Completion; Enterprise Activation and Monetization
ARLINGTON, Va., Dec. 30, 2025 (GLOBE NEWSWIRE) -- OBOOK Holdings Inc. (NASDAQ:…
Best NAD+ Injection for 2026: Sprout Health Lists Compounded NAD+ at $149 First Month as Telehealth Longevity Programs Expand
ENCINITAS, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for…
ImmuCell Announces Strategic Focus on First Defense After Receiving an FDA Incomplete Letter for Re-Tain
December 24, 2025 13:05 ET | Source: ImmuCell Corporation PORTLAND, Maine, Dec.…
DLC Guide Mumbai Second Edition 2025 Concludes, Strengthening India’s First Global Hospitality Rating System
MUMBAI, India, Dec. 24, 2025 /PRNewswire/ -- The DLC Guide Mumbai Second Edition…
Curium Announces First Commercial Doses of PYLCLARI for Patients with Prostate Cancer in Poland
PYLCLARI® provides solutions to a wider patient group across Poland where there…
ADEPT 2026: Anant National University Opens Admissions with India’s First Multi-Lingual Design Entrance Test
Scheduled for 4 January 2026, the exam will be held online in…
Biosplice Therapeutics Announces First Patient Dosed in InvestigatorInitiated Phase 1 Clinical Trial of Cirtuvivint and Olaparib in BRCA/HRD PlatinumResistant Ovarian Cancer
SAN DIEGO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”),…
